Phathom Pharmaceuticals. All rights reserved. VOQUEZNA, VOQUEZNA DUAL PAK, VOQUEZNA TRIPLE PAK, Phathom Pharmaceuticals, and their respective logos are registered trademarks of Phathom Pharmaceuticals ...

Phathom Pharmaceuticals said Friday that BDR Pharmaceuticals International has sued the US Food and Drug Administration, or FDA, challenging its alleged refusal to accept a generic ...

Biopharmaceutical company Phathom Pharmaceuticals, Inc. announced on Friday that Mumbai, India-based BDR Pharmaceuticals International Pvt. Ltd. has filed a lawsuit against the U.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A live webcast and additional information about the presentation can be accessed on the Events & Presentations section of the Phathom website at A recording will be available for 90 days following ...

Hello and welcome to the Phathom Pharmaceuticals’ First Quarter 2025 Earnings Results Call. [Operator Instructions] Please be advised that today’s conference is being recorded. With that, I would like ...

All right. I think we're ready to go. Welcome to the last presentation of the day at the Barclays Miami Healthcare Conference. My name is Jenna Davidner. I'm one of the analysts on the specialty ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Phathom Pharmaceuticals, Inc. (PHAT) came out with a quarterly loss of $1.42 per share versus the Zacks Consensus Estimate of a loss of $1.43. This compares to loss of $0.89 per share a year ago.